List of Epi E Z Pen Jr drug patents
Epi E Z Pen Jr is owned by Mylan Speciality Lp.
Epi E Z Pen Jr contains Epinephrine.
Epi E Z Pen Jr has a total of 5 drug patents out of which 0 drug patents have expired.
Epi E Z Pen Jr was authorised for market use on 22 December, 1987.
Epi E Z Pen Jr is available in injectable;intramuscular, subcutaneous dosage forms.
The generics of Epi E Z Pen Jr are possible to be released after 11 September, 2025.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8870827 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(2 years from now) | |
| US9586010 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(2 years from now) | |
| US7794432 | MYLAN SPECIALITY LP | Automatic injector with kickback attenuation |
Sep, 2025
(2 years from now) | |
| US7449012 | MYLAN SPECIALITY LP | Automatic injector |
Sep, 2025
(2 years from now) | |
| US8048035 | MYLAN SPECIALITY LP | Automatic injector with needle cover |
Sep, 2025
(2 years from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 22 December, 1987
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic